Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-25

Clinical Trial Update: Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

View source ↗

Summary

This clinical trial update reports on the adequacy of a new pediatric HRZ tablet (isoniazid/rifampin/pyrazinamide) for treating tuberculosis in patients with HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)
  • Pyrazinamide (pyrazinamide)
  • RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: University of Florida | Conditions: Tuberculosis, Human Immunodeficiency Virus | Status: COMPLETED